CTRI/2023/05/052624已完成Unknown
A Non blinded Randomized Controlled Trial to assess the efficacy of Helicobacter pylori eradication in patients with chronic urticaria
试验速览
- 阶段
- Unknown
- 状态
- 已完成
- 入组人数
- 110
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •All clinically diagnosed cases of chronic urticaria with a positive result in the Helicobacter pylori stool antigen test
排除标准
- •Patients taking proton pump inhibitors/ H2 blockers/ antibiotics/ oral steroids in last 2 weeks
研究者
相似试验
进行中(未招募)
1 期
A Double-blind Randomized Controlled Trial to Assess the Lot-to-lot Consistency of Sci-B-Vac™ in AdultsHepatitis B VaccinationMedDRA version: 20.0 Level: LLT Classification code 10054181 Term: Hepatitis B immunization System Organ Class: 100000004865EUCTR2017-001820-22-DEVBI Vaccines INC.3,200
进行中(未招募)
1 期
A Double-blind Randomized Controlled Trial to Assess the Lot-to-lot Consistency of Sci-B-Vac™ in AdultsEUCTR2017-001820-22-GBVBI Vaccines INC.3,200
进行中(未招募)
1 期
A Double-blind Randomized Controlled Trial to Assess the Lot-to-lot Consistency of Sci-B-Vac™ in AdultsHepatitis B VaccinationMedDRA version: 20.0 Level: LLT Classification code 10054181 Term: Hepatitis B immunization System Organ Class: 100000004865EUCTR2017-001820-22-BEVBI Vaccines INC.3,200
进行中(未招募)
1 期
A Double-blind Randomized Controlled Trial to Assess the Lot-to-lot Consistency of Sci-B-Vac™ in AdultsHepatitis B VaccinationMedDRA version: 21.1 Level: LLT Classification code 10054181 Term: Hepatitis B immunization System Organ Class: 100000004865EUCTR2017-001820-22-FIVBI Vaccines INC.3,200
终止
不适用
An unblinded, randomised, controlled trial to assess patient care and outcomes of standard outpatient care and telephone consultation.People who have been referred to a Nephrologist and ongoing careRenal and Urogenital - Kidney diseasePublic Health - Health service researchkidney diseaseACTRN12613000741785ambour General Hospital60
